🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — November 2025 Page 8

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — November 2025

LabKate Sat, Mar 14, 2026 at 9:46 PM 36 replies 1,552 viewsPage 8 of 8
B12Beth
Member
289
890
Oct 2024
Maryland
Apr 17, 2026 at 8:00 PM#36
anders_CPH said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

23 21GraceAZ_72, carl_compliance, DanielChem_CHI and 20 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Apr 19, 2026 at 4:36 PM#37
anders_CPH said:
If you are going to change something, change one thing and give it long enough to express itself.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

24 22Dr.RheumBOS, greg_boulder, quinn_sf and 21 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Apr 21, 2026 at 1:11 PM#38

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

25 23tommy_boulder, hyun_seoul, jim_asheville and 22 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Apr 23, 2026 at 9:44 AM#39
DeniseRN_TPA said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This matches mine closely enough to be worth saying so out loud.

Last edited: Apr 23, 2026 at 11:44 AM
26 24Dr.PathRoch, mona_PHX, andrew_nyc and 23 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Apr 25, 2026 at 6:16 AM#40
DeniseRN_TPA said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding the part of the answer the thread has not reached. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

48 21BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 45 others
Reply Quote Save Share Report
1678

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register